Life sciences R&D is evolving rapidly. We’ve experienced a surge in new research and therapeutic modalities. Innovative life science companies are aligning around scientific platforms and forming specialized teams with dedicated areas of expertise. This new R&D paradigm requires a higher degree of collaboration and data exchange, often amongst teams that are functionally or geographically distinct. Legacy software and bioinformatics infrastructure has left companies vulnerable to these new challenges. COVID-19 has exposed these vulnerabilities as teams have been forced to work remote from the lab and disconnected from each other.
Rashi Takkar, Product Marketing Manager at Benchling, will discuss approaches to embracing the new R&D paradigm, and the role software plays in driving structured data capture, exchange, and collaboration. In her role at Benchling, Rashi has observed hundreds of R&D transformations within life sciences R&D and will examine a case study of how one top biopharma company has worked with Benchling to bring about its next digital transformation.
Astrix Webinar – Computer System Validation: Best Practices and Navigating Challenges
A webinar sponsored by the Astrix Date: May 19th, 2021 Time: 1:00 […]
Read MoreAstrix to Present Keynote Address at 2021 Virtual STARLIMS Connect
“The Future of Laboratory Systems in a Digitally-Driven World” April 27th 11:15 […]
Read MoreAstrix Platinum Sponsor for 2021 USDA Virtual Technology Expo Series
April 13: USDA HQ and April 14: USDA Riverdale & GWCC Join […]
Read MoreAstrix Webinar – Why Are Biotechs And Midsize Pharmaceutical Organizations Choosing Lab Computing, Scientific Application Support and Lab Ambassador Managed Services?
A webinar sponsored by Astrix Date: Wednesday April 21, 2021 Time: 1:00 PM […]
Read MoreCopyright (C) 2021
732-661-0400
info@astrixinc.com
